These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 30464443

  • 21. Pressure-Flow During Exercise Catheterization Predicts Survival in Pulmonary Hypertension.
    Hasler ED, Müller-Mottet S, Furian M, Saxer S, Huber LC, Maggiorini M, Speich R, Bloch KE, Ulrich S.
    Chest; 2016 Jul; 150(1):57-67. PubMed ID: 26892603
    [Abstract] [Full Text] [Related]

  • 22. Cardiopulmonary Exercise Testing in Combined Pulmonary Fibrosis and Emphysema.
    Westhoff M, Litterst P, Ewert R.
    Respiration; 2021 Jul; 100(5):395-403. PubMed ID: 33657565
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Exercise-induced pulmonary hypertension by stress echocardiography: Prevalence and correlation with right heart hemodynamics.
    Misra D, Kendes A, Sulica R, Carabello B.
    Int J Cardiol; 2017 Feb 01; 228():518-522. PubMed ID: 27875728
    [Abstract] [Full Text] [Related]

  • 26. Ventilatory power, a cardiopulmonary exercise testing parameter for the prediction of pulmonary hypertension at right heart catheterization.
    Correale M, Monaco I, Ferraretti A, Tricarico L, Sicuranza M, Gallotta AM, Formica ES, Acanfora G, Di Biase M, Brunetti ND.
    Int J Cardiol Heart Vasc; 2020 Jun 01; 28():100513. PubMed ID: 32346602
    [Abstract] [Full Text] [Related]

  • 27. Ventilatory and cardiocirculatory exercise profiles in COPD: the role of pulmonary hypertension.
    Boerrigter BG, Bogaard HJ, Trip P, Groepenhoff H, Rietema H, Holverda S, Boonstra A, Postmus PE, Westerhof N, Vonk-Noordegraaf A.
    Chest; 2012 Nov 01; 142(5):1166-1174. PubMed ID: 22556320
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Abnormal pulmonary hemodynamics during exercise is associated with exercise capacity in COPD.
    Sassmann T, Douschan P, Foris V, Tröster N, Zeder K, Brcic L, Tornyos A, Bachmaier G, Fuchsjäger M, Olschewski H, Kovacs G.
    Respir Res; 2022 Dec 08; 23(1):331. PubMed ID: 36482405
    [Abstract] [Full Text] [Related]

  • 32. Exercise hypoxaemia as a predictor of pulmonary hypertension in COPD patients without severe resting hypoxaemia.
    Nakahara Y, Taniguchi H, Kimura T, Kondoh Y, Arizono S, Nishimura K, Sakamoto K, Ito S, Ando M, Hasegawa Y.
    Respirology; 2017 Jan 08; 22(1):120-125. PubMed ID: 27471142
    [Abstract] [Full Text] [Related]

  • 33. Exercise during cardiac catheterization distinguishes between pulmonary and left ventricular causes of dyspnea in systemic sclerosis patients.
    Hager WD, Collins I, Tate JP, Azrin M, Foley R, Lakshminarayanan S, Rothfield NF.
    Clin Respir J; 2013 Jul 08; 7(3):227-36. PubMed ID: 22789029
    [Abstract] [Full Text] [Related]

  • 34. Low resting diffusion capacity, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.
    Elbehairy AF, O'Donnell CD, Abd Elhameed A, Vincent SG, Milne KM, James MD, Webb KA, Neder JA, O'Donnell DE, Canadian Respiratory Research Network.
    J Appl Physiol (1985); 2019 Oct 01; 127(4):1107-1116. PubMed ID: 31369329
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Characterization of patients with borderline pulmonary arterial pressure.
    Kovacs G, Avian A, Tscherner M, Foris V, Bachmaier G, Olschewski A, Olschewski H.
    Chest; 2014 Dec 01; 146(6):1486-1493. PubMed ID: 25451346
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Role of vasoactive intestinal peptide in chronic obstructive pulmonary disease with pulmonary hypertension.
    Lacedonia D, Valerio G, Palladino GP, Carpagnano GE, Correale M, Di Biase M, Foschino Barbaro MP.
    Rejuvenation Res; 2014 Feb 01; 17(1):33-9. PubMed ID: 24228853
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.